Donghai Huang

1.8k total citations
60 papers, 1.3k citations indexed

About

Donghai Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Donghai Huang has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Donghai Huang's work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (10 papers) and Peptidase Inhibition and Analysis (9 papers). Donghai Huang is often cited by papers focused on RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (10 papers) and Peptidase Inhibition and Analysis (9 papers). Donghai Huang collaborates with scholars based in China, United States and South Sudan. Donghai Huang's co-authors include Yongquan Tian, Yuanzheng Qiu, Xin Zhang, Yong Liu, Gangcai Zhu, Zhongwu Su, Chao Liu, Li She, Shuling Ren and Songqing Fan and has published in prestigious journals such as ACS Nano, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Donghai Huang

59 papers receiving 1.3k citations

Peers

Donghai Huang
Yun Zhu China
Kristy A. Warner United States
Edwardine Labay United States
Ina Kurth Germany
Donghai Huang
Citations per year, relative to Donghai Huang Donghai Huang (= 1×) peers Dongwang Zhu

Countries citing papers authored by Donghai Huang

Since Specialization
Citations

This map shows the geographic impact of Donghai Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghai Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghai Huang more than expected).

Fields of papers citing papers by Donghai Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghai Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghai Huang. The network helps show where Donghai Huang may publish in the future.

Co-authorship network of co-authors of Donghai Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Donghai Huang. A scholar is included among the top collaborators of Donghai Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghai Huang. Donghai Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gao, Yan, et al.. (2023). Modifiable factors for benign salivary gland neoplasms: A Mendelian randomization study. Oral Diseases. 30(4). 2245–2253. 3 indexed citations
3.
Liu, Chao, Li Guo, Siyuan Zheng, et al.. (2023). PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation. Biology Direct. 18(1). 39–39. 4 indexed citations
4.
He, Zhiying, Yitao Mao, Shanhong Lu, et al.. (2022). Machine learning–based radiomics for histological classification of parotid tumors using morphological MRI: a comparative study. European Radiology. 32(12). 8099–8110. 24 indexed citations
5.
Tian, Yuxi, Huimei Huang, Donghai Huang, et al.. (2021). The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site. Oral Oncology. 125. 105675–105675. 9 indexed citations
6.
Zhang, Fen, Huimei Huang, Yuexiang Qin, et al.. (2021). MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment. iScience. 24(10). 103102–103102. 9 indexed citations
7.
Zhu, Gangcai, Chang‐Han Chen, Siyuan Zheng, et al.. (2021). A characterization and prognosis prediction model for primary squamous cell carcinoma of the thyroid. Gland Surgery. 10(4). 1325–1338. 3 indexed citations
8.
Zhu, Gangcai, Yimin Xu, Siyuan Zheng, et al.. (2021). Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review With Meta-Analysis. Frontiers in Immunology. 12. 627226–627226. 19 indexed citations
9.
Li, Zhexuan, Chang‐Han Chen, Juncheng Wang, et al.. (2021). Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma. PeerJ. 9. e10746–e10746. 31 indexed citations
10.
Liu, Yijun, Zhicheng Wang, Meilin Chen, et al.. (2020). Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma. Journal of Clinical Laboratory Analysis. 34(8). e23298–e23298. 4 indexed citations
11.
Chen, Xiyu, Chao Liu, Li Guo, et al.. (2020). <p>UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 6191–6202. 9 indexed citations
12.
She, Li, Yuexiang Qin, Juncheng Wang, et al.. (2018). Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck. Cancer Cell International. 18(1). 120–120. 47 indexed citations
13.
Zhu, Gangcai, Li She, Ming Wei, et al.. (2017). Elevated expression of Derlin-1 associates with unfavorable survival time of squamous cell carcinoma of the head and neck and promotes its malignance. Journal of Cancer. 8(12). 2336–2345. 9 indexed citations
15.
Li, Jiao, Qiuyuan Wen, Lina Xu, et al.. (2014). Fatty acid synthase–associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma. Human Pathology. 45(12). 2447–2452. 12 indexed citations
16.
Wang, Dongsheng, Susan J. Muller, A.R.M. Ruhul Amin, et al.. (2012). The Pivotal Role of Integrin β1 in Metastasis of Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 18(17). 4589–4599. 39 indexed citations
17.
Liu, Yong, Donghai Huang, Caiping Ren, et al.. (2012). Increased expression of Rab coupling protein in squamous cell carcinoma of the head and neck and its clinical significance. Oncology Letters. 3(6). 1231–1236. 13 indexed citations
18.
Qi, Lin, Ping Wu, Xin Zhang, et al.. (2011). Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines. Medical Oncology. 29(2). 721–728. 27 indexed citations
19.
Ge, Linhu, Wenlong Shao, Zhang Yang-de, et al.. (2011). RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells. Oncology Letters. 2(6). 1121–1129. 13 indexed citations
20.
Liu, Yong, Xin Zhang, Yuanzheng Qiu, et al.. (2010). Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck. Journal of Cancer Research and Clinical Oncology. 137(5). 761–769. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026